Brought to you by 
PPD licenses rights to Eli Lilly's genitourinary compounds
22 Dec 2003
Executive Summary
Pharmaceutical Product Development has licensed worldwide rights to a number of Eli Lilly's genitourinary compounds outside of Lilly's core research focus, including those that target bladder and sexual dysfunction.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Joint Venture
- R&D and Marketing (Licensing)
- Reverse Licensing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PPD licenses rights to Eli Lilly's genitourinary compounds
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice